Use of Ephedra-containing products and risk for hemorrhagic stroke

L. B. Morgenstern; C. M. Viscoli; W. N. Kernan; L. M. Brass; J. P. Broderick; E. Feldmann; J. L. Wilterdink; T. Brott; R. I. Horwitz

doi:10.1212/01.WNL.0000042092.20411.5B

Use of Ephedra-containing products and risk for hemorrhagic stroke

L. B. Morgenstern, C. M. Viscoli, W. N. Kernan, L. M. Brass, J. P. Broderick, E. Feldmann, J. L. Wilterdink, T. Brott, R. I. Horwitz

Neurology

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Abstract

This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of ≥32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.

Original language	English (US)
Pages (from-to)	132-135
Number of pages	4
Journal	Neurology
Volume	60
Issue number	1
DOIs	https://doi.org/10.1212/01.WNL.0000042092.20411.5B
State	Published - Jan 14 2003

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.WNL.0000042092.20411.5B

Cite this

@article{ba512df393714699b222cb8e7c22e4e2,

title = "Use of Ephedra-containing products and risk for hemorrhagic stroke",

abstract = "This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of ≥32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.",

author = "Morgenstern, {L. B.} and Viscoli, {C. M.} and Kernan, {W. N.} and Brass, {L. M.} and Broderick, {J. P.} and E. Feldmann and Wilterdink, {J. L.} and T. Brott and Horwitz, {R. I.}",

year = "2003",

month = jan,

day = "14",

doi = "10.1212/01.WNL.0000042092.20411.5B",

language = "English (US)",

volume = "60",

pages = "132--135",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Use of Ephedra-containing products and risk for hemorrhagic stroke

AU - Morgenstern, L. B.

AU - Viscoli, C. M.

AU - Kernan, W. N.

AU - Brass, L. M.

AU - Broderick, J. P.

AU - Feldmann, E.

AU - Wilterdink, J. L.

AU - Brott, T.

AU - Horwitz, R. I.

PY - 2003/1/14

Y1 - 2003/1/14

N2 - This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of ≥32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.

AB - This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of ≥32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.

UR - http://www.scopus.com/inward/record.url?scp=0037435503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037435503&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000042092.20411.5B

DO - 10.1212/01.WNL.0000042092.20411.5B

M3 - Article

C2 - 12525737

AN - SCOPUS:0037435503

SN - 0028-3878

VL - 60

SP - 132

EP - 135

JO - Neurology

JF - Neurology

IS - 1

ER -

Use of Ephedra-containing products and risk for hemorrhagic stroke

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this